Trials / Completed
CompletedNCT02490111
Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer
Efficacy and Safety of DWJ1319 in the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer: A Multicenter, Randomized, Double-blind, Placebo-controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 521 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy and safety of DWJ1319 in the prevention of gallstone formation after gastrectomy in patient with gastric cancer. Two-thirds of the participants will receive DWJ1319, while the other will receive a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1319 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2015-07-03
- Last updated
- 2019-02-08
Locations
12 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02490111. Inclusion in this directory is not an endorsement.